On the other hand the tendency of more severe deregulation of RBSP3 transcription during tumor progression was more evident for AC cases: in average a 3-fold declined expression in 70% of cases without metastases and a 6-fold in 88% of samples with metastases. The gene discussed is CTDSPL; the disease is neoplasm.